Searched for
DRUG PRICING VIOLATIONS
Drugmakers may bear sole responsibility for overpricing essential medicines under NPPA proposalThe National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential med...- School assembly news headlines, August 27: National, international, business, sports and education headlines for studentsSchool assembly news headlines, August 27: Floods in Nepal have caused fatalities and missing persons, prompting humanitarian aid from Indi...
- F&B regulatory crackdown sends celebrities into endorsement rethinkSeveral celebrities and influencers have stopped endorsing food and beverage brands. This action follows increased regulatory oversight and...
- The buck stops somewhere else: A look at Trump's tendency to avoid blame when things go awryUS President Donald Trump has repeatedly blamed predecessors and others for economic, foreign-policy and domestic problems, drawing scrutin...
- Maharashtra Motor Vehicle Aggregator Rules 2026 notified: From surge pricing to private carpooling to Rs 1 crore penalty, what changes for Ola, Uber, Rapido usersMaharashtra has notified new rules for app-based transport services, bringing aggregators under a uniform framework. These regulations mand...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOver the next few trading sessions, the direction of indices like the Nifty and Sensex will be determined by news on ceasefire violations a...
- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
- Maharashtra FDA bans serving food in newspapers, issues statewide food safety orderMaharashtra FDA has launched 'Safe Food, Healthy Maharashtra' banning food served on newspapers and enforcing strict hygiene. Hotels, resta...
- ITC bulking up with products rich in protein and fibre: Sanjiv Puri“India is also a protein-deficient market. We already have offerings such as high-protein atta, soya chunks and protein shakes, and we will...
- Staggering amounts of fentanyl hit US streets as the DEA watched and took no action, records showDEA agents in New Mexico allegedly allowed hundreds of thousands of fentanyl pills onto streets between 2023-2025, prioritizing larger case...
- Plan in the works to let hospitals import med equipment directlyIndia's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- Drug price regulator finds 4,700 medicines illegally over-pricedThe national drug price regulator NPPA has warned of action against companies violating its pricing norms as it found prices of more than 4...
- Prices of around 12,000 drug SKUs decline in January: NPPAPrices of around 12,000 stock keeping units (SKUs) of medicines have come down during January this year as a consequence of implementation ...
- Overcharging drug cos may have to cough up huge finesDrug companies including Ranbaxy Laboratories, Dr Reddy’s Laboratories (DRL) and Lupin may have to pay over Rs 1,600 crore as penalties for...
- Drug regulator in strict enforcement modeDrug majors like Ranbaxy, Dr Reddy’s, GlaxoSmithKline, Cadila Pharma and Lupin may have a lesson to learn from the trouble they have landed...
- NPPA takes action against 93 drug brandsIt is pay-back time for drug-makers who tried to coax the government into a softer pricing regime by offering to cut the prices of 886 bran...
- NPPA asks pharmas to make good promise on price cutsPharma majors Cadila Healthcare, Alembic, Emcure, Lupin, Medley Pharmaceuticals and Wockhardt have found themselves in a tight spot after t...
- Drug cos' price cut offer helps NPPA fix offendersThe pharmaceutical industry’s recent offer to cut prices of 886 medicines to dissuade the government from going ahead with a tougher pricin...
- Drug makers may lose their licence for price violationThe government is arming itself with greater powers through a new law to rein in pharma corporations violating price control notifications.
Load More
